MDxHealth SA (MDXH)
0.6972
-0.02
(-2.28%)
USD |
NASDAQ |
Sep 09, 16:00
0.6972
0.00 (0.00%)
After-Hours: 17:45
MDxHealth EPS Diluted (Quarterly) : -0.2245 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2245 |
| March 31, 2026 | -0.1726 |
| December 31, 2025 | -0.1741 |
| September 30, 2025 | -0.1618 |
| June 30, 2025 | -0.1489 |
| March 31, 2025 | -0.186 |
| December 31, 2024 | -0.14 |
| September 30, 2024 | -0.40 |
| June 30, 2024 | -0.4225 |
| March 31, 2024 | -0.3119 |
| December 31, 2023 | -0.3928 |
| September 30, 2023 | -0.3715 |
| June 30, 2023 | -0.393 |
| March 31, 2023 | -0.50 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -0.4557 |
| BioRestorative Therapies, Inc. | -2.431 |
| CareDx, Inc. | 2.071 |
| Natera, Inc. | -0.4674 |
| Exagen, Inc. | -0.1323 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.478M |
| Revenue (Quarterly) | 27.21M |
| Total Expenses (Quarterly) | 36.69M |
| Enterprise Value | 123.29M |
| Gross Profit Margin (Quarterly) | 61.13% |
| Profit Margin (Quarterly) | -34.83% |
| Earnings Yield | -105.1% |
| Normalized Earnings Yield | -105.13 |